Health News Roundup: U.S. FDA approves AstraZeneca's Tagrisso-chemo combo; Denali-Sanofi's ALS drug fails to meet mid-stage trial goal and more

The drug would be used to treat adults with a type of advanced lung cancer, AstraZeneca said, adding that the FDA's approval was based on trials which extended median progression-free survival (PFS) by nearly nine months. Daiichi invests 1 billion eur near Munich to make precision cancer drugs Daiichi Sankyo said on Friday it would invest about 1 billion euros ($1.07 billion) to expand a site near Munich, Germany, to boost its work on precision cancer drugs.